94P Does hyperprogressive disease predict poor survival?

Saved in:
Bibliographic Details
Published in:Immuno-oncology technology 2022-12, Vol.16, p.100198, Article 100198
Main Authors: Alkan, G., Senturk Oztas, N., Degerli, E., Turna, Z.H., Ozguroglu, M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 100198
container_title Immuno-oncology technology
container_volume 16
creator Alkan, G.
Senturk Oztas, N.
Degerli, E.
Turna, Z.H.
Ozguroglu, M.
description
doi_str_mv 10.1016/j.iotech.2022.100198
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_iotech_2022_100198</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1016_j_iotech_2022_100198</sourcerecordid><originalsourceid>FETCH-LOGICAL-c918-983e2276538b710ab6ad1a1e74c37fe52af723427fd40ccacf8ad2f8c7465b1a3</originalsourceid><addsrcrecordid>eNpNz8tqwzAUBFBRWmhI8wdd6AfsXj1sSasS0icE2kX2QpavGpkUGSkx5O_b4C66mmEWA4eQewY1A9Y-DHVMR_T7mgPnvxMwo6_IgjcGKmBaX__rt2RVygAAXBkJGhZEG_lJnxIWuj-PmMecvjKWEiekfSzoCtIxYx_9kY4pZVpOeYqTOzzekZvgDgVXf7kku5fn3eat2n68vm_W28obpiujBXKu2kboTjFwXet65hgq6YUK2HAXFBeSq9BL8N75oF3Pg_ZKtk3HnFgSOd_6nErJGOyY47fLZ8vAXvx2sLPfXvx29osf0cBQPg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>94P Does hyperprogressive disease predict poor survival?</title><source>ScienceDirect®</source><source>PubMed Central</source><creator>Alkan, G. ; Senturk Oztas, N. ; Degerli, E. ; Turna, Z.H. ; Ozguroglu, M.</creator><creatorcontrib>Alkan, G. ; Senturk Oztas, N. ; Degerli, E. ; Turna, Z.H. ; Ozguroglu, M.</creatorcontrib><identifier>ISSN: 2590-0188</identifier><identifier>EISSN: 2590-0188</identifier><identifier>DOI: 10.1016/j.iotech.2022.100198</identifier><language>eng</language><ispartof>Immuno-oncology technology, 2022-12, Vol.16, p.100198, Article 100198</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Alkan, G.</creatorcontrib><creatorcontrib>Senturk Oztas, N.</creatorcontrib><creatorcontrib>Degerli, E.</creatorcontrib><creatorcontrib>Turna, Z.H.</creatorcontrib><creatorcontrib>Ozguroglu, M.</creatorcontrib><title>94P Does hyperprogressive disease predict poor survival?</title><title>Immuno-oncology technology</title><issn>2590-0188</issn><issn>2590-0188</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpNz8tqwzAUBFBRWmhI8wdd6AfsXj1sSasS0icE2kX2QpavGpkUGSkx5O_b4C66mmEWA4eQewY1A9Y-DHVMR_T7mgPnvxMwo6_IgjcGKmBaX__rt2RVygAAXBkJGhZEG_lJnxIWuj-PmMecvjKWEiekfSzoCtIxYx_9kY4pZVpOeYqTOzzekZvgDgVXf7kku5fn3eat2n68vm_W28obpiujBXKu2kboTjFwXet65hgq6YUK2HAXFBeSq9BL8N75oF3Pg_ZKtk3HnFgSOd_6nErJGOyY47fLZ8vAXvx2sLPfXvx29osf0cBQPg</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Alkan, G.</creator><creator>Senturk Oztas, N.</creator><creator>Degerli, E.</creator><creator>Turna, Z.H.</creator><creator>Ozguroglu, M.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202212</creationdate><title>94P Does hyperprogressive disease predict poor survival?</title><author>Alkan, G. ; Senturk Oztas, N. ; Degerli, E. ; Turna, Z.H. ; Ozguroglu, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c918-983e2276538b710ab6ad1a1e74c37fe52af723427fd40ccacf8ad2f8c7465b1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alkan, G.</creatorcontrib><creatorcontrib>Senturk Oztas, N.</creatorcontrib><creatorcontrib>Degerli, E.</creatorcontrib><creatorcontrib>Turna, Z.H.</creatorcontrib><creatorcontrib>Ozguroglu, M.</creatorcontrib><collection>CrossRef</collection><jtitle>Immuno-oncology technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alkan, G.</au><au>Senturk Oztas, N.</au><au>Degerli, E.</au><au>Turna, Z.H.</au><au>Ozguroglu, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>94P Does hyperprogressive disease predict poor survival?</atitle><jtitle>Immuno-oncology technology</jtitle><date>2022-12</date><risdate>2022</risdate><volume>16</volume><spage>100198</spage><pages>100198-</pages><artnum>100198</artnum><issn>2590-0188</issn><eissn>2590-0188</eissn><doi>10.1016/j.iotech.2022.100198</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2590-0188
ispartof Immuno-oncology technology, 2022-12, Vol.16, p.100198, Article 100198
issn 2590-0188
2590-0188
language eng
recordid cdi_crossref_primary_10_1016_j_iotech_2022_100198
source ScienceDirect®; PubMed Central
title 94P Does hyperprogressive disease predict poor survival?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T04%3A31%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=94P%20Does%20hyperprogressive%20disease%20predict%20poor%20survival?&rft.jtitle=Immuno-oncology%20technology&rft.au=Alkan,%20G.&rft.date=2022-12&rft.volume=16&rft.spage=100198&rft.pages=100198-&rft.artnum=100198&rft.issn=2590-0188&rft.eissn=2590-0188&rft_id=info:doi/10.1016/j.iotech.2022.100198&rft_dat=%3Ccrossref%3E10_1016_j_iotech_2022_100198%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c918-983e2276538b710ab6ad1a1e74c37fe52af723427fd40ccacf8ad2f8c7465b1a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true